GLN-OLMESARTAN

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: ea49a40bbd73f43c
Drug Approval Canada Name: GLN-OLMESARTAN
Product Name: GLN-OLMESARTAN
Status: Marketed
Status Date: 2019-03-05
Original Market Date: 2019-03-05
Din: 02469820
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:32.08
Atc Original: C09CA08 OLMESARTAN MEDOXOMIL
Atc Name: c 09 ca 08
Aig Number: 0152496003
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

OLMESARTAN MEDOXOMIL

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ea49a40bbd73f43c

Type

Standard